NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lead Pharma

Lead Pharma

Private
DeventerHealthcare & Life Scienceshttps://leadpharma.com/

Last Round

Buyout/LBO

Mar 6, 2026

Total Funding Raised

$11.84M

Company Overview

Lead Pharma is a biopharmaceutical company that discovers and develops innovative small-molecule therapies for the treatment of autoimmune diseases, metabolic diseases, and cancer.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

drug discoverysmall-molecule therapycomputational chemistrymedicinal chemistryin silico drug discoveryai drug discoverybiotech licensingpre-clinical researchoncology researchautoimmune disease researchbiomarker developmentassay developmentpharma r&dtechbiodrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lead Pharma Comparables

Compare Lead Pharma with similar companies based on industry and business-model similarity.

Lead Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phenex Pharmaceuticals AG
81%
Odyssey Therapeutics
78%
Evotec
74%

Lead Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Buyout/LBOMar 6, 2026
StrategicNov 16, 2020
StrategicFeb 18, 2015

Lead Pharma Investors

Notable investors and investment history

Lead Pharma investors
InvestorRounds
819 Capital PartnersBuyout/LBO
Waterman VenturesBuyout/LBO
East Netherlands Development Agency (Oost NL)Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 7, 2026

    Monthly visitors increased 73% MoM.

Lead Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lead Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lead Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersDeventer
Employee Range20
Year FoundedN/A
Last FundingMar 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.